Skip to main content

Table 1 Descriptive statistics

From: A clinical study of inferior alveolar nerve damage caused by Carnoy’s solution used as a complementary therapeutic agent in a cystic lesion

Variables

Attributes

Categorical variables

 Sex

Males: 57 (74%)

Females: 20 (26%)

 CS use

CS use: 19 (24.7%)

No use: 58 (75.3%)

 Sensory recovery

Normal (NRS = 8–10): 57 (74%)

Not normal (NRS = below 8): 20 (26%)

 Diagnosis

OKC: 14 (18.2%), UAM: 5 (6.5%), DC: 30 (39%), RC: 28 (36.4%)

Interval variables

Minimum

Maximum

Mean

Std. deviation

 Age

11

76

39.56

14.42

 Follow-up period in months

10

66

36.96

13.91

 Invasion size

1

3

1.91

0.83

 NRS right after cyst enucleation

    

 Total (77)

02

10

7.94

2.58

 CS group (19)

02

10

6.68

3.25

 Non-CS group (58)

02

10

8.34

2.20

 NRS at the end of the follow-up period

    

 Total (77)

02

10

8.61

2.14

 CS group (19)

02

10

8.00

2.86

 Non-CS group (58)

03

10

8.81

1.84

  1. Note: OKC odontogenic keratocyst, UAM unicystic ameloblastoma, DC dentigerous cyst, RC radicular cyst, CS Carnoy’s solution, NRS numeric rating scale